Canesi M - Search Results

1

An overnight switch to ropinirole therapy in patients with Parkinson's disease. Short communication.

Canesi M, Antonini A, Mariani CB, Tesei S, Zecchinelli AL, Barichella M, Pezzoli G. Canesi M, et al. J Neural Transm (Vienna). 1999;106(9-10):925-9. doi: 10.1007/s007020050212. J Neural Transm (Vienna). 1999. PMID: 10599874

2

Amantadine for Friedreich's ataxia.

Mariani C, Canesi M, Barbieri S, Pezzoli G. Mariani C, et al. Among authors: canesi m. Neurology. 1990 Jan;40(1):194. doi: 10.1212/wnl.40.1.194. Neurology. 1990. PMID: 2296376 No abstract available.

3

n-Hexane-induced parkinsonism: pathogenetic hypotheses.

Pezzoli G, Antonini A, Barbieri S, Canesi M, Perbellini L, Zecchinelli A, Mariani CB, Bonetti A, Leenders KL. Pezzoli G, et al. Among authors: canesi m. Mov Disord. 1995 May;10(3):279-82. doi: 10.1002/mds.870100308. Mov Disord. 1995. PMID: 7651443

4

Frontal dysfunction in early Parkinson's disease.

Farina E, Cappa SF, Polimeni M, Magni E, Canesi M, Zecchinelli A, Scarlato G, Mariani C. Farina E, et al. Among authors: canesi m. Acta Neurol Scand. 1994 Jul;90(1):34-8. doi: 10.1111/j.1600-0404.1994.tb02676.x. Acta Neurol Scand. 1994. PMID: 7941954

5

Biochemical and physiological aspects of 2,5-hexanedione: endogenous or exogenous product?

Perbellini L, Pezzoli G, Brugnone F, Canesi M. Perbellini L, et al. Among authors: canesi m. Int Arch Occup Environ Health. 1993;65(1):49-52. doi: 10.1007/BF00586058. Int Arch Occup Environ Health. 1993. PMID: 8354575

6

Pergolide mesylate in Parkinson's disease treatment.

Pezzoli G, Canesi M, Pesenti A, Mariani CB. Pezzoli G, et al. Among authors: canesi m. J Neural Transm Suppl. 1995;45:203-12. J Neural Transm Suppl. 1995. PMID: 8748627 Review.

7

Effects of acute n-hexane and 2,5-hexanedione treatment on the striatal dopaminergic system in mice.

Masotto C, Bisiani C, Camisasca C, Fusi R, Ricciardi S, Fonzi N, Perbellini L, Scatturin M, Mariani CB, Canesi M, et al. Masotto C, et al. Among authors: canesi m. J Neural Transm Suppl. 1995;45:281-5. J Neural Transm Suppl. 1995. PMID: 8748636

8

T1 and T2 in the brain of healthy subjects, patients with Parkinson disease, and patients with multiple system atrophy: relation to iron content.

Vymazal J, Righini A, Brooks RA, Canesi M, Mariani C, Leonardi M, Pezzoli G. Vymazal J, et al. Among authors: canesi m. Radiology. 1999 May;211(2):489-95. doi: 10.1148/radiology.211.2.r99ma53489. Radiology. 1999. PMID: 10228533 Clinical Trial.

9

Hydrocarbon exposure and Parkinson's disease.

Pezzoli G, Canesi M, Antonini A, Righini A, Perbellini L, Barichella M, Mariani CB, Tenconi F, Tesei S, Zecchinelli A, Leenders KL. Pezzoli G, et al. Among authors: canesi m. Neurology. 2000 Sep 12;55(5):667-73. doi: 10.1212/wnl.55.5.667. Neurology. 2000. PMID: 10980731

10

Tolerability of paroxetine in Parkinson's disease: a prospective study.

Tesei S, Antonini A, Canesi M, Zecchinelli A, Mariani CB, Pezzoli G. Tesei S, et al. Among authors: canesi m. Mov Disord. 2000 Sep;15(5):986-9. doi: 10.1002/1531-8257(200009)15:5<986::aid-mds1034>3.0.co;2-i. Mov Disord. 2000. PMID: 11009210 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

128 results

Search Page